Trump's Campaign Signals Collaboration With RFK Jr. On Major FDA Reforms

By Maaisha Osman / October 30, 2024 at 7:08 PM

Donald Trump’s campaign is signaling to Inside Health Policy that the GOP candidate’s proposed chronic disease commission might incorporate several ideas championed by Robert F. Kennedy Jr., including revamping FDA’s user fee program that makes up 75% of the agency’s budget, reducing pharmaceutical influence in health agency decisions and removing chemicals from food.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.